Teofarma Srl Teofarma dentosedina neo 15g

• 2 stelle, basato su 1 voti

Teofarma dentosedina neo active principles 100 grams of solution contain: active ingredients: hydrochloric acid 9,50 g; benzocaine 1.

excipients ethylene glycol, propylene glycol.

therapeutic indications dental analgesic for outdoor use.

contraindications / undesirable effects hypersensitivity already known to anesthetics.

dosage spray lightly one or two times the liquid on the sore or dental cavity, keep the liquid around for about five minutes, and then expel it.

the application can be repeated several times.

do not exceed the recommended doses of your doctor: in particular elderly patients should comply with the minimum doses indicated.

use only for short periods of treatment.

storage none.

warnings absorption: the topical use of anesthetics in high concentration, through absorbing through mucous membranes or severely damaged skin, can cause systemic symptoms of considerable magnitude such as central nervous system depression, respiratory depression, hypotension, and heart rhythm alterations.

for this reason caution should be exercised when using local anesthetics, especially in cases of heavily damaged mucous membranes.

subjects treated with local dental anesthetics during the first period should consult the dentist every day.

sensitization: the use of prolonged use of topical products may lead to sensitization (skin redness, itching, difficulty breathing, collapse): if an allergic reaction occurs, immediately discontinue use of the medicine and consult a physician.

allergic reactions may occur for cross-reaction phenomena in patients already allergic to other local anesthetics: these patients should therefore avoid using the product.

special precautions for certain categories of patients : the use of local anesthetics should be avoided in elderly and debilitated subjects, in seizures, shock states, in patients with severe myasthenia, in patients with severe hepatic or renal failure, in patients with thyrotoxicosis, cardiovascular disease.

interactions the drug may inhibit the therapeutic effects of sulphonamides.

side effects allergic reactions are known in hypersensitive subjects: they may also occur after the first administration for the subjects hypersensitivity.

in severe cases, which have been exceptionally described with the use of local anesthetics in high concentrations for absorption through the skin or damaged mucosa, systemic symptoms of significant magnitude can be observed such as respiratory depression, central nervous system depression, hypotension, heart rhythm alterations; it has been reported that benzocaine can cause metaemoglobinemia at high doses, usually unreachable with the use of dentosedin.

overdose overdose cases have not been reported in literature.

pregnancy and breastfeeding if a woman intends to become pregnant or suspected of being pregnant, she should consult her doctor before using this medicine.

do not administer the product in the first trimester of pregnancy; in the further period you should only be given if it is actually needed and under the direct medical supervision.

as the amount of absorbed anesthetic is not known and its possible elimination through breast milk, it is advised not to take the product to breast-feeding women.